𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson’s disease

✍ Scribed by Richard W. Walker; Anna R. Howells; William K. Gray

Book ID
116820864
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
111 KB
Volume
17
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of histamine H2 receptor antagoni
Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP-macaque model of Parkinson's disease
✍ Tom H. Johnston; Anne van der Meij; Jonathan M. Brotchie; Susan H. Fox 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 823 KB

## Abstract Levodopa‐induced motor complications, including dyskinesia and wearing off, are troublesome side effects of treatment and impair quality of life in Parkinson's disease (PD) patients. The use of nondopaminergic agents as adjuncts to levodopa are potential options for managing these probl

Short-term effect of a single levodopa d
Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
✍ Tomoyuki Uchiyama; Ryuji Sakakibara; Takamichi Hattori; Tomonori Yamanishi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB 👁 1 views

## Abstract We investigated the short‐term effects of a single dose of levodopa (L‐dopa) on micturition function in PD patients with wearing‐off phenomenon. Eighteen PD patients who had median Hoehn and Yahr scores of 5 during the __off__ phase and 3 during the __on__ phase were recruited. We carri

Onset of dyskinesia with adjunct ropinir
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
✍ Ray L. Watts; Kelly E. Lyons; Rajesh Pahwa; Kapil Sethi; Matthew Stern; Robert A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Levodopa-induced dyskinesia can result in significant functional disability and reduced quality of life in patients with Parkinson's disease (PD). The goal of this study was to determine if the addition of once-daily ropinirole 24hour prolonged-release (n 5 104) in PD patients not optimally controll